Late-Phase Oncology Research

Global Support for Late-phase Oncology Clinical Research

Catalyst Oncology successfully supports the global, late–phase research needs of biotech.

Global execution for late-phase oncology clinical trials

Catalyst Oncology manages Phase II and Phase III studies across the globe with our network of skilled clinical trial professionals, patient recruitment experts, and access to 500+ cancer centers, including top US institutions. We offer deep therapeutic and functional expertise. We provide a strong understanding of the differing start-up timelines, and ethical and regulatory requirements across regions.

Why choose Catalyst Oncology for late-phase clinical studies?

Catalyst Oncology helps move life-changing oncology therapies through the complex and dynamic clinical trial environment with workable solutions, best-in-class technologies, and a data-centric approach.

Learn More

Global site expertise

Catalyst Oncology works with 500+ cancer centers around the globe, including, experience with all of the top 15 cancer centers in the US.

Global oncology expertise

Multi-regional trials are essential for late–phase studies. Catalyst Oncology’s footprint across North America, Europe, and Asia-Pacific enables us to seamlessly implement Phase II and III studies on a global scale.

Therapeutic focus

With a biotech- and oncology-only focus, we cater to late–phase trial optimization and deliver tailored solutions. Our expertise spans solid tumors, hematological malignancies, and rare hematological oncology indications.

Operational proficiency

Experience managing oncology registrational studies and other oncology knowledge are critical to the success of a trial’s design, data review, and output. Catalyst Oncology exhibits deep oncology experience across the clinical team and operational functions.

Flexible solutions and best-in-class technologies

Whether you need contract resources, single function, or full-service CRO support, we remain flexible to fit your needs or budget. We offer best-in-class solutions that leverage industry-leading technologies and people to support studies with novel endpoints and complex designs.

Data-centric approach

Catalyst Oncology offers a technology-enabled solution that promotes transparency of data and metrics through our proprietary clinical analytics tool. Catalytics was configured by a cross-functional team of oncology drug development veterans to accelerate informed decisions and optimize oncology trial performance.

The project team anticipates and provides solution-based responses to the current challenges on a given study, which is the essential need for any Sponsor as each protocol evolves and changes based on the clinical data collected.

My Catalyst team is an extension of my internal team. The team is very transparent and communicative. They are aware of the trial timelines and each department helps to keep the study on track.

Experience the Catalyst Oncology Difference

Explore our comprehensive late–phase research capabilities and learn how Catalyst Oncology can support your global oncology trials.

Start Your Late-phase Oncology Trial with Catalyst Oncology